Bal Pharma has informed that the meeting of the Board of Directors of the Company is scheduled on 10/08/2021, to consider and approve Un audited financial results (Standalone and Consolidated) of the Company for the quarter ended 30.06.2021; allotment of stock options to the employees under Bal Pharma - Employee Stock Option Scheme -2014; and any other matters relating to Annual General Meeting.
The above information is a part of company’s filings submitted to BSE.